Citations (96)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (17)
Luca Degli Esposti, Chiara Veronesi, Domenica Daniela Ancona, Margherita Andretta, Fausto Bartolini, Alberto Drei, Alessandro Lupi, Stefano Palcic, Davide Re, Francesca Vittoria Rizzi, Elisa Giacomini & Valentina Perrone. (2022) Direct Healthcare Costs by Level of Adherence of a Real-World Population of Statin Users in Italy. ClinicoEconomics and Outcomes Research 14, pages 139-147.
Read now
Read now
Constantine E Kosmas, Alba Muñoz Estrella, Andreas Skavdis, Edilberto Peña Genao, Ian Martinez & Eliscer Guzman. (2020) Inclisiran for the Treatment of Cardiovascular Disease: A Short Review on the Emerging Data and Therapeutic Potential. Therapeutics and Clinical Risk Management 16, pages 1031-1037.
Read now
Read now
Najmeh Ahangari, Mohammad Doosti, Majid Ghayour Mobarhan, Amirhossein Sahebkar, Gordon A. Ferns & Alireza Pasdar. (2020) Personalised medicine in hypercholesterolaemia: the role of pharmacogenetics in statin therapy. Annals of Medicine 52:8, pages 462-470.
Read now
Read now
Anika Steinert, Cornelia Eicher, Marten Haesner & Elisabeth Steinhagen-Thiessen. (2020) Effects of a long-term smartphone-based self-monitoring intervention in patients with lipid metabolism disorders. Assistive Technology 32:2, pages 109-116.
Read now
Read now
Monira Alwhaibi, Maha Altoaimi, Yazed AlRuthia, Abdulkarim M Meraya, Bander Balkhi, Ahmed Aldemerdash, Hadeel Alkofide, Tariq M Alhawassi, Abdulmajeed Alqasoumi & Khalid M Kamal. (2019) Adherence to Statin Therapy and Attainment of LDL Cholesterol Goal Among Patients with Type 2 Diabetes and Dyslipidemia. Patient Preference and Adherence 13, pages 2111-2118.
Read now
Read now
Constantine E Kosmas, Delia Silverio, Julio Ovalle, Peter D Montan & Eliscer Guzman. (2018) Patient adherence, compliance, and perspectives on evolocumab for the management of resistant hypercholesterolemia. Patient Preference and Adherence 12, pages 2263-2266.
Read now
Read now
Hans Wouters, Marcel L Bouvy, Erica CG Van Geffen, Helga Gardarsdottir, Anne M Stiggelbout & Liset Van Dijk. (2014) Antidepressants in primary care: patients’ experiences, perceptions, self-efficacy beliefs, and nonadherence. Patient Preference and Adherence 8, pages 179-190.
Read now
Read now
Helen I Keen, Janakan Krishnarajah, Timothy R Bates & Gerald F Watts. (2014) Statin myopathy: the fly in the ointment for the prevention of cardiovascular disease in the 21st century?. Expert Opinion on Drug Safety 13:9, pages 1227-1239.
Read now
Read now
Manuela Casula, Elena Tragni & Alberico Luigi Catapano. (2012) Adherence to lipid-lowering treatment: the patient perspective. Patient Preference and Adherence 6, pages 805-814.
Read now
Read now
Hua Ling, Tammy L. Burns & Daniel E. Hilleman. (2012) Novel Strategies for Managing Dyslipidemia: Treatment beyond Statins. Postgraduate Medicine 124:6, pages 43-54.
Read now
Read now
Yves Muscat Baron, Mark Brincat & Raymond Galea. (2012) Iliac vessel wall thickness in menstrual and hormone treated and untreated postmenopausal women. Gynecological Endocrinology 28:5, pages 409-412.
Read now
Read now
Gerald F Watts & Fredrik Karpe. (2011) Why, when and how should hypertriglyceridemia be treated in the high-risk cardiovascular patient?. Expert Review of Cardiovascular Therapy 9:8, pages 987-997.
Read now
Read now
Siddhesh A. Kamat, Michael F. Bullano, Chun-Lan Chang, Sanjay K. Gandhi & Mark J. Cziraky. (2011) Adherence to single-pill combination versus multiple-pill combination lipid-modifying therapy among patients with mixed dyslipidemia in a managed care population. Current Medical Research and Opinion 27:5, pages 961-968.
Read now
Read now
Jeffrey A Pfefferkorn. (2011) Novel 3-hydroxy-3-methylglutaryl-coenzyme A reductase inhibitors: a patent review. Expert Opinion on Therapeutic Patents 21:2, pages 187-203.
Read now
Read now
Dick C Chan & Gerald F Watts. (2011) Dyslipidaemia in the metabolic syndrome and type 2 diabetes: pathogenesis, priorities, pharmacotherapies. Expert Opinion on Pharmacotherapy 12:1, pages 13-30.
Read now
Read now
Giovanni Battista Vigna & Renato Fellin. (2010) Pharmacotherapy of dyslipidemias in the adult population. Expert Opinion on Pharmacotherapy 11:18, pages 3041-3052.
Read now
Read now
Julia F. Slejko, Robert L. Page$suffix/text()$suffix/text() & Patrick W. Sullivan. (2010) Cost-effectiveness of statin therapy for vascular event prevention in adults with elevated C-reactive protein: implications of JUPITER. Current Medical Research and Opinion 26:10, pages 2485-2497.
Read now
Read now
Articles from other publishers (79)
Milan Gupta, Rajvi J. Wani, Khalid Al Faraidy, Jean Bergeron, Eduardo Contreras, Angel Alberto Garcia Peña, G. B. John Mancini, Francisco Padilla, Abel Alberto Pavia Lopez, Kiran Philip, Johnny Wu & Erin S. Mackinnon. (2023) Real-World Insights into Evolocumab Use in Patients with Hyperlipidemia Across Five Countries: Analysis from the ZERBINI Study. Cardiology and Therapy 12:4, pages 703-722.
Crossref
Crossref
Ermiyas Melaku, Esubalew Tesfahun Ayele, Besufekad Mulugeta Urgie, Getachew Bizuneh Ayidagnuhim, Erzik Hassen & Aklile Semu Tefera. (2023) Appropriate Use of Primary Statin Preventive Therapy Among Patients with High Atherosclerosis-Related Cardiovascular Disease Risks: Cross-Sectional Study, Northeast Ethiopia. Vascular Health and Risk Management Volume 19, pages 707-718.
Crossref
Crossref
Mark J. Butler, Anne-Marie N. Romain, Rumisha Augustin, Patrick Robles, Ciaran P. Friel, Thevaa Chandereng, Jerry M. Suls, Elizabeth A. Vrany, Frank Vicari, Ying Kuen Cheung & Karina W. Davidson. (2023) The effect of a multi-component behavior change technique intervention on medication adherence among individuals on primary prevention statin therapy: a dose-finding protocol. Trials 24:1.
Crossref
Crossref
Haiyan Li, Xiaoni Jia, Hui Min, Yingli Zhang, Huichuan Wang & Yuyao Zhai. (2023) Relationships between beliefs about statins and non-adherence in inpatients from Northwestern China: a cross-sectional survey. Frontiers in Pharmacology 14.
Crossref
Crossref
Kirthi S. Bellamkonda, Cheryl Zogg, Naiem Nassiri, Mehran M. Sadeghi, Yawei Zhang, Raul J. Guzman & Cassius Iyad Ochoa Chaar. (2023) Characteristics and 1-year outcomes of patients with rupture of small abdominal aortic aneurysms. Journal of Vascular Surgery 77:6, pages 1649-1657.
Crossref
Crossref
Francesco Baratta, Francesco Angelico & Maria Del Ben. (2023) Challenges in Improving Adherence to Diet and Drug Treatment in Hypercholesterolemia Patients. International Journal of Environmental Research and Public Health 20:10, pages 5878.
Crossref
Crossref
C. Justin Brown, Lee-Shing Chang, Naoshi Hosomura, Shervin Malmasi, Fritha Morrison, Maria Shubina, Zhou Lan & Alexander Turchin. (2023) Assessment of Sex Disparities in Nonacceptance of Statin Therapy and Low-Density Lipoprotein Cholesterol Levels Among Patients at High Cardiovascular Risk. JAMA Network Open 6:2, pages e231047.
Crossref
Crossref
Xu Zhou, Jianwei Yu, Qing Wan, Wei Wang, Xinyu Yu, Jianyu You, Hui Ouyang, Xiaofan Chen, Yuan Cong, Shuailiang Huang, Jianchun Song, Kaimin Zhu, Yongmei Guan & Weifeng Zhu. (2022) Efficacy and safety of Pueraria lobata radix and Pueraria thomsonii radix for patients with mild dyslipidemia: A randomized, double-blind, placebo-controlled trial. Journal of Functional Foods 98, pages 105284.
Crossref
Crossref
Lamija Ferhatbegović, Denis Mršić, Sabina Kušljugić & Belma Pojskić. (2022) LDL-C: The Only Causal Risk Factor for ASCVD. Why Is It Still Overlooked and Underestimated?. Current Atherosclerosis Reports 24:8, pages 635-642.
Crossref
Crossref
Milan Gupta, G.B. John Mancini, Rajvi J. Wani, Vineeta Ahooja, Jean Bergeron, Priya Manjoo, A. Shekhar Pandey, Maureen Reiner, Johnny Beltran, Thiago Oliveira & Erin S. Mackinnon. (2022) Real-World Insights Into Evolocumab Use in Patients With Hyperlipidemia: Canadian Analysis From the ZERBINI Study. CJC Open 4:6, pages 558-567.
Crossref
Crossref
Zhirong Yang, Sengwee Toh, Xiaojuan Li, Duncan Edwards, Carol Brayne & Jonathan Mant. (2022) Statin use is associated with lower risk of dementia in stroke patients: a community-based cohort study with inverse probability weighted marginal structural model analysis. European Journal of Epidemiology 37:6, pages 615-627.
Crossref
Crossref
Gary J. Martin, Meron Teklu, Edwin Mandieka & Joe Feinglass. (2022) Low-Density Lipoprotein Cholesterol Levels in Coronary Artery Disease Patients: Opportunities for Improvement. Cardiology Research and Practice 2022, pages 1-7.
Crossref
Crossref
Pengfan Li, Qi Wang, Kanjun Chen, Shihui Zou, Shi Shu, Chanchan Lu, Shiyun Wang, Yunqin Jiang, Chunxiang Fan & Yue Luo. (2022) Red Yeast Rice for Hyperlipidemia: A Meta-Analysis of 15 High-Quality Randomized Controlled Trials. Frontiers in Pharmacology 12.
Crossref
Crossref
Antoinette Schoenthaler & Sheba Sethi. 2022. Handbook of Cardiovascular Behavioral Medicine. Handbook of Cardiovascular Behavioral Medicine
441
470
.
Patrick J. Campbell, David R. Axon, Ann M. Taylor, Karen Smith, Matthew Pickering, Heather Black, Terri Warholak & Chanadda Chinthammit. (2021) Hypertension, cholesterol and diabetes medication adherence, health care utilization and expenditure in a Medicare Supplemental sample. Medicine 100:35, pages e27143.
Crossref
Crossref
Renata Cristina Rezende Macedo do Nascimento, Tanja Mueller, Brian Godman, Sean MacBride Stewart, Simon Hurding, Francisco Assis Acurcio, Augusto Afonso Guerra Junior, Juliana Alvares Teodoro, Alec Morton, Marion Bennie & Amanj Kurdi. (2020) Real‐world evaluation of the impact of statin intensity on adherence and persistence to therapy: A Scottish population‐based study. British Journal of Clinical Pharmacology 86:12, pages 2349-2361.
Crossref
Crossref
Christoph Ehlken, Focke Ziemssen, Nicole Eter, Ines Lanzl, Hakan Kaymak, Albrecht Lommatzsch & Alexander K. Schuster. (2020) Systematic review: non-adherence and non-persistence in intravitreal treatment. Graefe's Archive for Clinical and Experimental Ophthalmology 258:10, pages 2077-2090.
Crossref
Crossref
João Paulo Vilela Rodrigues, Lucas Borges Pereira, Maria Olívia Barboza Zanetti, Andréia Turmina Fontanella, Nereida Kilza da Costa Lima, Sotero Serrate Mengue & Leonardo Régis Leira Pereira. (2020) Use of statins for the secondary prevention of stroke: are we respecting the scientific evidences?. Journal of Stroke and Cerebrovascular Diseases 29:8, pages 104912.
Crossref
Crossref
Elena Olmastroni, Mezio T. Boccalari, Elena Tragni, Federico Rea, Luca Merlino, Giovanni Corrao, Alberico L. Catapano & Manuela Casula. (2020) Sex-differences in factors and outcomes associated with adherence to statin therapy in primary care: Need for customisation strategies. Pharmacological Research 155, pages 104514.
Crossref
Crossref
Guangyan Mu, Qian Xiang, Shuang Zhou, Zhiyan Liu, Litong Qi, Jie Jiang, Yanjun Gong, Qiufen Xie, Zining Wang, Hanxu Zhang, Yong Huo & Yimin Cui. (2020) Efficacy and Safety of PCSK9 Monoclonal Antibodies in Patients at High Cardiovascular Risk: An Updated Systematic Review and Meta-Analysis of 32 Randomized Controlled Trials. Advances in Therapy 37:4, pages 1496-1521.
Crossref
Crossref
Manuel E. Machado-Duque, Andrés Gaviria-Mendoza & Jorge E. Machado-Alba. (2020) Real-World Effectiveness of Therapy With Rosuvastatin Combined With Fenofibric Acid in a Sample of Colombian Patients With Mixed Dyslipidemia. Journal of Primary Care & Community Health 11, pages 215013272097773.
Crossref
Crossref
Alanna M. Chamberlain, Sarah S. Cohen, Jill M. Killian, Keri L. Monda, Susan A. Weston & Ted Okerson. (2019) Lipid-Lowering Prescription Patterns in Patients With Diabetes Mellitus or Cardiovascular Disease. The American Journal of Cardiology 124:7, pages 995-1001.
Crossref
Crossref
Fengzhu Ang, Jing En Pau, En Wei Koh, Nicholas Kwan Liang Loh, Weini Yeoh, Joshua Weiguang Liang, Christine B. Teng & Kai Zhen Yap. (2019) Drug-related problems associated with community-dwelling older persons living alone in Singapore. International Journal of Clinical Pharmacy 41:3, pages 719-727.
Crossref
Crossref
Eli Bjørnøy Urke, Silje Søbye, Asta Ellingvåg, Gisle Langslet, Kjetil Retterstøl & Margareta Wandel. (2019) Familial hypercholesterolemia and young patients’ thoughts on own condition and treatment. Patient Education and Counseling 102:5, pages 1005-1012.
Crossref
Crossref
Leah L. Zullig, Lisa Egbuonu-Davis, Anjali Trasy, Christiana Oshotse, Karen M. Goldstein & Hayden B. Bosworth. (2018) Countering clinical inertia in lipid management: Expert workshop summary. American Heart Journal 206, pages 24-29.
Crossref
Crossref
Matthew P. Banegas, Marc A. Emerson, Alyce S. Adams, Ninah S. Achacoso, Neetu Chawla, Stacey Alexeeff & Laurel A. Habel. (2018) Patterns of medication adherence in a multi-ethnic cohort of prevalent statin users diagnosed with breast, prostate, or colorectal cancer. Journal of Cancer Survivorship 12:6, pages 794-802.
Crossref
Crossref
Yoonyoung Park, Hyuna Yang, Amar K. Das & Gigi Yuen-Reed. (2018) Prescription fill rates for acute and chronic medications in claims-EMR linked data. Medicine 97:44, pages e13110.
Crossref
Crossref
Mariana Veronez Borgo, Marcelo Perim Baldo, Rafael de Oliveira Alvim, Divanei Zaniqueli, Daniel Pires Capingana, Pedro Magalhães, Amilcar Bernardo da Silva, Polyana Romano Oliosa, Carmem Luiza Sartório & José Geraldo Mill. (2018) Lipid disorders among Black Africans non-users of lipid-lowering medication. Archives of Endocrinology and Metabolism 62:5, pages 552-559.
Crossref
Crossref
Sofie Rosenlund Lau & Margit Kriegbaum. (2018) Medication non-adherence in the context of situated uncertainty: Moving beyond simple, dichotomous approaches. Research in Social and Administrative Pharmacy 14:8, pages 742-748.
Crossref
Crossref
Sewon Jeong, Jaekyung Lee, Oran Kwon, Ji Won Kim & Bumjo Oh. (2018) A randomized, double-blind, placebo-controlled trial investigating cholesterol-lowering effects and safety of yellow yeast rice in adults with mild to moderate hypercholesterolemia. Medicine 97:30, pages e11634.
Crossref
Crossref
Karen Krüger, Niklas Leppkes, Sabine Gehrke-Beck, Wolfram Herrmann, Engi A Algharably, Reinhold Kreutz, Christoph Heintze & Iris Filler. (2018) Improving long-term adherence to statin therapy: a qualitative study of GPs’ experiences in primary care. British Journal of General Practice 68:671, pages e401-e407.
Crossref
Crossref
Mohamed Hassan Elnaem, Mohamad Haniki Nik Mohamed, Hasniza Zaman Huri & Shah M Azarisman. (2018) Impact of educational outreach intervention on enhancing health care providers' knowledge about statin therapy prescribing in Malaysian patients with type 2 diabetes mellitus. Journal of Evaluation in Clinical Practice 24:3, pages 521-527.
Crossref
Crossref
Christina M. Gant, S. Heleen Binnenmars, Manon Harmelink, Sabita S. Soedamah-Muthu, Stephan J. L. Bakker, Gerjan Navis & Gozewijn D. Laverman. (2018) Real-life achievement of lipid-lowering treatment targets in the DIAbetes and LifEstyle Cohort Twente: systemic assessment of pharmacological and nutritional factors. Nutrition & Diabetes 8:1.
Crossref
Crossref
William King, Arron Lacey, James White, Daniel Farewell, Frank Dunstan & David Fone. (2018) Socioeconomic inequality in medication persistence in primary and secondary prevention of coronary heart disease – A population-wide electronic cohort study. PLOS ONE 13:3, pages e0194081.
Crossref
Crossref
Barak Zafrir, Ayman Jubran, Gil Lavie, David A Halon, Moshe Y Flugelman & Chen Shapira. (2017) Clinical determinants and treatment gaps in familial hypercholesterolemia: Data from a multi-ethnic regional health service. European Journal of Preventive Cardiology 24:8, pages 867-875.
Crossref
Crossref
Wietske Kievit, Jake S. F. Maurits, Elke E. Arts, Piet L. C. M. van Riel, Jaap Fransen & Calin D. Popa. (2017) Cost‐Effectiveness of Cardiovascular Screening in Patients With Rheumatoid Arthritis. Arthritis Care & Research 69:2, pages 175-182.
Crossref
Crossref
Johnny W. Bai, Geneviève Boulet, Elise M. Halpern, Leif E. Lovblom, Devrim Eldelekli, Hillary A. Keenan, Michael Brent, Narinder Paul, Vera Bril, David Z. I. Cherney, Alanna Weisman & Bruce A. Perkins. (2016) Cardiovascular disease guideline adherence and self-reported statin use in longstanding type 1 diabetes: results from the Canadian study of longevity in diabetes cohort. Cardiovascular Diabetology 15:1.
Crossref
Crossref
Joshua A. Rash, David J.T. Campbell, Marcello Tonelli & Tavis S. Campbell. (2016) A systematic review of interventions to improve adherence to statin medication: What do we know about what works?. Preventive Medicine 90, pages 155-169.
Crossref
Crossref
Nathan D. Wong, Daphnee Young, Yanglu Zhao, Huy Nguyen, Jared Caballes, Irfan Khan & Robert J. Sanchez. (2016) Prevalence of the American College of Cardiology/American Heart Association statin eligibility groups, statin use, and low-density lipoprotein cholesterol control in US adults using the National Health and Nutrition Examination Survey 2011–2012. Journal of Clinical Lipidology 10:5, pages 1109-1118.
Crossref
Crossref
Jonathan Schofield, See Kwok, Michael France, Nigel Capps, Ruth Eatough, Rahul Yadav, Kausik Ray & Handrean Soran. (2016) Knowledge gaps in the management of familial hypercholesterolaemia. A UK based survey. Atherosclerosis 252, pages 161-165.
Crossref
Crossref
Joshua A. Rash, Kim L. Lavoie, Ronald J. Sigal, David J.T. Campbell, Braden J. Manns, Marcello Tonelli & Tavis S. Campbell. (2016) The OPTIMIZE trial: Rationale and design of a randomized controlled trial of motivational enhancement therapy to improve adherence to statin medication. Contemporary Clinical Trials 49, pages 47-56.
Crossref
Crossref
Gisle Langslet, Martin P. Bogsrud, Ida Halvorsen, Heidi Fjeldstad, Kjetil Retterstøl, Marit B. Veierød & Leiv Ose. (2015) Long-term follow-up of young adults with familial hypercholesterolemia after participation in clinical trials during childhood. Journal of Clinical Lipidology 9:6, pages 778-785.
Crossref
Crossref
Reza Izadpanah, Deborah J. SchächteleAndreas B. PfnürDong LinDouglas P. Slakey, Philip J. Kadowitz & Eckhard U. Alt. (2015) The impact of statins on biological characteristics of stem cells provides a novel explanation for their pleiotropic beneficial and adverse clinical effects. American Journal of Physiology-Cell Physiology 309:8, pages C522-C531.
Crossref
Crossref
Albert Wiegman, Samuel S. Gidding, Gerald F. Watts, M. John Chapman, Henry N. Ginsberg, Marina Cuchel, Leiv Ose, Maurizio Averna, Catherine Boileau, Jan Borén, Eric Bruckert, Alberico L. Catapano, Joep C. Defesche, Olivier S. Descamps, Robert A. Hegele, G. Kees Hovingh, Steve E. Humphries, Petri T. Kovanen, Jan Albert Kuivenhoven, Luis Masana, Børge G. Nordestgaard, Päivi Pajukanta, Klaus G. Parhofer, Frederick J. Raal, Kausik K. Ray, Raul D. Santos, Anton F.H. Stalenhoef, Elisabeth Steinhagen- Thiessen, Erik S. Stroes, Marja-Riitta Taskinen, Anne Tybjærg-Hansen & Olov Wiklund. (2015) Familial hypercholesterolaemia in children and adolescents: gaining decades of life by optimizing detection and treatment. European Heart Journal 36:36, pages 2425-2437.
Crossref
Crossref
Alexander Turin, Jay Pandit & Neil J. Stone. (2015) Statins and Nonadherence. Journal of Cardiovascular Pharmacology and Therapeutics 20:5, pages 447-456.
Crossref
Crossref
Maaike C. Gerards, Ruben J. Terlou, Huixin Yu, C.H.W. Koks & V.E.A. Gerdes. (2015) Traditional Chinese lipid-lowering agent red yeast rice results in significant LDL reduction but safety is uncertain – A systematic review and meta-analysis. Atherosclerosis 240:2, pages 415-423.
Crossref
Crossref
Hans Wouters, Anne M. Stiggelbout, Marcel L. Bouvy, Gemma A. Maatman, Erica C.G. Van Geffen, Robbert Vree, Johan W. Nortier & Liset Van Dijk. (2014) Endocrine Therapy for Breast Cancer: Assessing an Array of Women's Treatment Experiences and Perceptions, Their Perceived Self-Efficacy and Nonadherence. Clinical Breast Cancer 14:6, pages 460-467.e2.
Crossref
Crossref
Jorge Alberto Salazar-Gonzalez, Sergio Rosales-Mendoza, Andrea Romero-Maldonado, Elizabeth Monreal-Escalante, Edith Elena Uresti-Rivera & Bernardo Bañuelos-Hernández. (2014) Production of a Plant-Derived Immunogenic Protein Targeting ApoB100 and CETP: Toward a Plant-Based Atherosclerosis Vaccine. Molecular Biotechnology 56:12, pages 1133-1142.
Crossref
Crossref
Daniel A. Devcich, Christopher J. Ellis, Natasha Waltham, Elizabeth Broadbent & Keith J. Petrie. (2014) Seeing what's happening on the inside: Patients' views of the value of diagnostic cardiac computed tomography angiography. British Journal of Health Psychology 19:4, pages 810-822.
Crossref
Crossref
Stephen T. Higgins. (2014) Behavior change, health, and health disparities: An introduction. Preventive Medicine 68, pages 1-4.
Crossref
Crossref
YJ Chee, V Chan & NC Tan. (2014) Understanding patients’ perspective of statin therapy: can we design a better approach to the management of dyslipidaemia? A literature review. Singapore Medical Journal 55:8, pages 416-421.
Crossref
Crossref
Sandra McKellar & Paul Fulbrook. (2014) Compliance with lipid-lowering medication after diagnosis of coronary heart disease. British Journal of Cardiac Nursing 9:5, pages 244-249.
Crossref
Crossref
Natarajan Harivenkatesh, Darling Chellathai David, Natarajan Haribalaji & Muthiah Kothandaramanujam Sudhakar. (2014) Efficacy and Safety of Alternate Day Therapy With Atorvastatin and Fenofibrate Combination in Mixed Dyslipidemia. Journal of Cardiovascular Pharmacology and Therapeutics 19:3, pages 296-303.
Crossref
Crossref
Damon A. Bell, Jacquie Garton-Smith, Alistair Vickery, Andrew B. Kirke, Jing Pang, Timothy R. Bates & Gerald F. Watts. (2014) Familial Hypercholesterolaemia in Primary Care: Knowledge and Practices among General Practitioners in Western Australia. Heart, Lung and Circulation 23:4, pages 309-313.
Crossref
Crossref
J. M. H. Galema-Boers, M. J. Lenzen, R. T. van Domburg, J. Roeters van Lennep, G. G. van Bruchem-van de Scheur, E. J. Sijbrands & J. G. Langendonk. (2014) Predicting non-adherence in patients with familial hypercholesterolemia. European Journal of Clinical Pharmacology 70:4, pages 391-397.
Crossref
Crossref
Gerald F. Watts, Samuel Gidding, Anthony S. Wierzbicki, Peter P. Toth, Rodrigo Alonso, W. Virgil Brown, Eric Bruckert, Joep Defesche, Khoo Kah Lin, Michael Livingston, Pedro Mata, Klaus G. Parhofer, Frederick J. Raal, Raul D. Santos, Eric J.G. Sijbrands, William G. Simpson, David R. Sullivan, Andrey V. Susekov, Brian Tomlinson, Albert Wiegman, Shizuya Yamashita & John J.P. Kastelein. (2014) Integrated guidance on the care of familial hypercholesterolemia from the International FH Foundation. Journal of Clinical Lipidology 8:2, pages 148-172.
Crossref
Crossref
Gerald F. Watts, Samuel Gidding, Anthony S. Wierzbicki, Peter P. Toth, Rodrigo Alonso, W. Virgil Brown, Eric Bruckert, Joep Defesche, Khoo Kah Lin, Michael Livingston, Pedro Mata, Klaus G. Parhofer, Frederick J. Raal, Raul D. Santos, Eric J.G. Sijbrands, William G. Simpson, David R. Sullivan, Andrey V. Susekov, Brian Tomlinson, Albert Wiegman, Shizuya Yamashita & John J.P. Kastelein. (2014) Integrated guidance on the care of familial hypercholesterolaemia from the International FH Foundation. International Journal of Cardiology 171:3, pages 309-325.
Crossref
Crossref
Hans Wouters, Erica C.G. van Geffen, Monique C. Baas-Thijssen, Elly M. Krol-Warmerdam, Anne M. Stiggelbout, Svetlana Belitser, Marcel L. Bouvy & Liset van Dijk. (2013) Disentangling breast cancer patients' perceptions and experiences with regard to endocrine therapy: Nature and relevance for non-adherence. The Breast 22:5, pages 661-666.
Crossref
Crossref
Melissa Y. Wei, Matthew K. Ito, Jerome D. Cohen, Eliot A. Brinton & Terry A. Jacobson. (2013) Predictors of statin adherence, switching, and discontinuation in the USAGE survey: Understanding the use of statins in America and gaps in patient education. Journal of Clinical Lipidology 7:5, pages 472-483.
Crossref
Crossref
Helle Wallach-Kildemoes, Morten Andersen, Finn Diderichsen & Theis Lange. (2013) Adherence to preventive statin therapy according to socioeconomic position. European Journal of Clinical Pharmacology 69:8, pages 1553-1563.
Crossref
Crossref
Varsha G. Vimalananda, Donald R. Miller, Timothy P. Hofer, Robert G. Holleman, Mandi L. Klamerus & Eve A. Kerr. (2013) Accounting for Clinical Action Reduces Estimates of Gender Disparities in Lipid Management for Diabetic Veterans. Journal of General Internal Medicine 28:S2, pages 529-535.
Crossref
Crossref
Yoshie Onishi, Shiro Hinotsu, Yoko M. Nakao, Hisashi Urushihara & Koji Kawakami. (2013) Economic Evaluation of Pravastatin for Primary Prevention of Coronary Artery Disease Based on Risk Prediction from JALS-ECC in Japan. Value in Health Regional Issues 2:1, pages 5-12.
Crossref
Crossref
Jorge Alberto Salazar-González & Sergio Rosales-Mendoza. (2013) A perspective for atherosclerosis vaccination: Is there a place for plant-based vaccines?. Vaccine 31:10, pages 1364-1369.
Crossref
Crossref
Julia A. Glombiewski, Yvonne Nestoriuc, Winfried Rief, Heide Glaesmer & Elmar Braehler. (2012) Medication Adherence in the General Population. PLoS ONE 7:12, pages e50537.
Crossref
Crossref
Folgerdiena M. de Vries, Petra Denig, Koen B. Pouwels, Maarten J. Postma & Eelko Hak. (2012) Primary Prevention of Major Cardiovascular and Cerebrovascular Events with Statins in Diabetic Patients. Drugs 72:18, pages 2365-2373.
Crossref
Crossref
Helle Wallach-Kildemoes, Finn Diderichsen, Allan Krasnik, Theis Lange & Morten Andersen. (2012) Is the high-risk strategy to prevent cardiovascular disease equitable? A pharmacoepidemiological cohort study. BMC Public Health 12:1.
Crossref
Crossref
Ines Krass, Adrian T. Walker & Gerald F. Watts. (2012) Detection and care of familial hypercholesterolaemia in the community: is there a role for the pharmacist?. International Journal of Clinical Pharmacy 34:4, pages 501-505.
Crossref
Crossref
Hein A. van Onzenoort, Cees Neef, Willem W. Verberk, H. Peter van Iperen, Peter W. de Leeuw & Paul-Hugo M. van der Kuy. (2012) Determining the feasibility of objective adherence measurement with blister packaging smart technology. American Journal of Health-System Pharmacy 69:10, pages 872-879.
Crossref
Crossref
Margaret M. Redfield. (2012) Strategies to Screen for Stage B as a Heart Failure Prevention Intervention. Heart Failure Clinics 8:2, pages 285-296.
Crossref
Crossref
G. Panayiotou, V. Paschalis, M. G. Nikolaidis, A. A. Theodorou, C. K. Deli, N. Fotopoulou, I. G. Fatouros, Y. Koutedakis, M. Sampanis & A. Z. Jamurtas. (2012) No adverse effects of statins on muscle function and health-related parameters in the elderly: An exercise study. Scandinavian Journal of Medicine & Science in Sports, pages n/a-n/a.
Crossref
Crossref
Dale A Rublee, Shih-Yin Chen, Jack Mardekian, Ning Wu, Preethi Rao & Luke Boulanger. (2012) Evaluation of Cardiovascular Morbidity Associated with Adherence to Atorvastatin Therapy. American Journal of Therapeutics 19:1, pages 24-32.
Crossref
Crossref
Caroline HPA Van de Steeg-van Gompel, Michel Wensing & Peter AGM De Smet. (2011) Implementation of patient education at first and second dispensing of statins in Dutch community pharmacies: the sequel of a cluster randomized trial. BMC Health Services Research 11:1.
Crossref
Crossref
Gerald F Watts & Fredrik Karpe. (2011) Republished review: Triglycerides and atherogenic dyslipidaemia: extending treatment beyond statins in the high-risk cardiovascular patient. Postgraduate Medical Journal 87:1033, pages 776-782.
Crossref
Crossref
Gerald F. Watts, David R Sullivan, Nicola Poplawski, Frank van Bockxmeer, Ian Hamilton-Craig, Peter M. Clifton, Richard O’Brien, Warrick Bishop, Peter George, Phillip J. Barter, Timothy Bates, John R. Burnett, John Coakley, Patricia Davidson, Jon Emery, Andrew Martin, Waleed Farid, Lucinda Freeman, Elizabeth Geelhoed, Amanda Juniper, Alexa Kidd, Karam Kostner, Ines Krass, Michael Livingston, Suzy Maxwell, Peter O’Leary, Amal Owaimrin, Trevor G. Redgrave, Nicola Reid, Lynda Southwell, Graeme Suthers, Andrew Tonkin, Simon Towler & Ronald Trent. (2011) Familial hypercholesterolaemia: A model of care for Australasia. Atherosclerosis Supplements 12:2, pages 221-263.
Crossref
Crossref
Simone R.B.M. Eussen, Talitha L. Feenstra, Ido B. Toxopeus, Jeljer Hoekstra, Olaf H. Klungel, Hans Verhagen, Henk J. van Kranen & Cathy J.M. Rompelberg. (2011) Costs and health effects of adding functional foods containing phytosterols/-stanols to statin therapy in the prevention of cardiovascular disease. European Journal of Pharmacology 668, pages S91-S100.
Crossref
Crossref
M. C. S. Wong, J. Y. Jiang & S. M. Griffiths. (2011) Adherence to lipid-lowering agents among 11,042 patients in clinical practice. International Journal of Clinical Practice 65:7, pages 741-748.
Crossref
Crossref
Marissa A. Blum, Danielle Koo & Jalpa A. Doshi. (2011) Measurement and Rates of Persistence With and Adherence to Biologics for Rheumatoid Arthritis: A Systematic Review. Clinical Therapeutics 33:7, pages 901-913.
Crossref
Crossref
Ingrid C. Gelissen & Andrew J. Brown. (2011) Drug targets beyond HMG-CoA reductase: Why venture beyond the statins?. Frontiers in Biology 6:3, pages 197-205.
Crossref
Crossref
Kaustubh C. DabhadkarAmbar KulshreshthaMohammed K. AliK.M. Venkat Narayan. (2011) Prospects for a Cardiovascular Disease Prevention Polypill. Annual Review of Public Health 32:1, pages 23-38.
Crossref
Crossref